Work

A TME-activated photothermal agent with photodegradability for accurate breast tumor photothermal therapy

Year: 2025

Type: article

Abstract: metabolism and improving biosafety. Animal experiments demonstrated that IR780-PDA achieves specific tumor enrichment in breast cancer models and completely eradicates tumors, showcasing excellent therapeutic efficacy and good biocompatibility.

Source: RSC Advances

DOI: 10.1039/d5ra03064a

Authors: Weiqian Zhang, Weiqing Yue, Xiaoyi Shi, Liyun Lv, Zhijie Fang, Jie Li

Institution: Nanjing Tech University

Language: English

Topic: Nanoplatforms for cancer theranostics

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,042